Post
NPR
npr.org
did:plc:ln72v57ivz2g46uqf4xxqiuh
Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website. n.pr/4vZBhzc
https://n.pr/4vZBhzc
2026-04-22T13:41:32.551Z